U.S. Markets open in 3 hrs.

CH BIO CASSAVA (8129.HK)


HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.104-0.00 (-3.70%)
At close: 3:52PM HKT

CH BIO CASSAVA

COSCO Tower
Unit 3912
Central
Hong Kong
852 3104 8095
http://www.bio-cassava.com

SectorTechnology
IndustryTechnical & System Software
Full Time Employees28

Key Executives

NameTitlePayExercisedAge
Mr. Kin Chung KwanMD, Director of Restructuring for Group Bus.es & Corp. Investment and Exec. DirectorN/AN/A48
Mr. Yu Keung PoonCompliance Officer and Exec. Director518kN/A52
Mr. Ching Fung HungExec. Director498kN/A33
Mr. Lap Chin TangExec. DirectorN/AN/A64
Mr. Chung Yuen NgExec. DirectorN/AN/A64
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

China Bio Cassava Holdings Limited, an investment holding company, develops, sells, and licenses computer software and embedded systems in Hong Kong. The company’s products and services comprise Matrix mapping system, Q9 CIS, and Qcode Chinese character inputting system. It also researches and develops biotech renewable energy; and provides institution and corporate, and financing services. The company was formerly known as Bio Cassava Technology Holdings Limited and changed its name to China Bio Cassava Holdings Limited in June 2008. China Bio Cassava Holdings Limited was founded in 1995 and is based in Central, Hong Kong.

Corporate Governance

CH BIO CASSAVA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.